Evidence map›Paper›PMID 32884916›Full record

ReviewMedical journal of the Islamic Republic of Iran2020

Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review.

Aziz Rezapour, Saeide Alidoost, Asra Asgharzadeh, Zeynab Farhadi, Najme Khodadadi, Roghayeh Mohammadi Bakhsh, Razieh Sepehrian, Morteza Salemi, Masood Taheri Mirghaed, Masoud Behzadifar and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medical journal of the Islamic Republic of Iran, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review.Gout, urate, and crystal deposition disease · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aziz RezapourHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Saeide AlidoostHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-2604-9665
Asra AsgharzadehHealth Technology Assessment Group (HTAG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Zeynab FarhadiHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Najme KhodadadiHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Roghayeh Mohammadi BakhshHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Razieh SepehrianHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Morteza SalemiHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Masood Taheri MirghaedHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Masoud BehzadifarHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Rahim SohrabiHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllopurinolCost-EffectivenessEconomic evaluationFebuxostatGoutSystematic review

Identifiers

PMID32884916
PMCPMC7456432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.